FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310571009> ?p ?o ?g. }

• W4310571009 abstract "Multiple FGFR inhibitors are currently in clinical trials enrolling adults with different solid tumors, while very few enroll pediatric patients. We determined the types and frequency of FGFR alterations (FGFR1-4) in pediatric cancers to inform future clinical trial design.Tumors with FGFR alterations were identified from two large cohorts of pediatric solid tumors subjected to targeted DNA sequencing: The Dana-Farber/Boston Children's Profile Study (n = 888) and the multi-institution GAIN/iCAT2 (Genomic Assessment Improves Novel Therapy) Study (n = 571). Data from the combined patient population of 1,395 cases (64 patients were enrolled in both studies) were reviewed and cases in which an FGFR alteration was identified by OncoPanel sequencing were further assessed.We identified 41 patients with tumors harboring an oncogenic FGFR alteration. Median age at diagnosis was 8 years (range, 6 months-26 years). Diagnoses included 11 rhabdomyosarcomas, nine low-grade gliomas, and 17 other tumor types. Alterations included gain-of-function sequence variants (n = 19), amplifications (n = 10), oncogenic fusions (FGFR3::TACC3 [n = 3], FGFR1::TACC1 [n = 1], FGFR1::EBF2 [n = 1], FGFR1::CLIP2 [n = 1], and FGFR2::CTNNA3 [n = 1]), pathogenic-leaning variants of uncertain significance (n = 4), and amplification in combination with a pathogenic-leaning variant of uncertain significance (n = 1). Two novel FGFR1 fusions in two different patients were identified in this cohort, one of whom showed a response to an FGFR inhibitor.In summary, activating FGFR alterations were found in approximately 3% (41/1,395) of pediatric solid tumors, identifying a population of children with cancer who may be eligible and good candidates for trials evaluating FGFR-targeted therapy. Importantly, the genomic and clinical data from this study can help inform drug development in accordance with the Research to Accelerate Cures and Equity for Children Act." @default.
• W4310571009 created "2022-12-12" @default.
• W4310571009 creator A5001066329 @default.
• W4310571009 creator A5002118134 @default.
• W4310571009 creator A5016499103 @default.
• W4310571009 creator A5019837009 @default.
• W4310571009 creator A5019914745 @default.
• W4310571009 creator A5020118706 @default.
• W4310571009 creator A5020879855 @default.
• W4310571009 creator A5024176070 @default.
• W4310571009 creator A5030221990 @default.
• W4310571009 creator A5030622261 @default.
• W4310571009 creator A5034426537 @default.
• W4310571009 creator A5035004148 @default.
• W4310571009 creator A5043164726 @default.
• W4310571009 creator A5044409970 @default.
• W4310571009 creator A5046068707 @default.
• W4310571009 creator A5052728382 @default.
• W4310571009 creator A5053521833 @default.
• W4310571009 creator A5055885197 @default.
• W4310571009 creator A5056053037 @default.
• W4310571009 creator A5061278042 @default.
• W4310571009 creator A5063780804 @default.
• W4310571009 creator A5066809288 @default.
• W4310571009 creator A5071375150 @default.
• W4310571009 creator A5072705088 @default.
• W4310571009 creator A5083449660 @default.
• W4310571009 creator A5084270347 @default.
• W4310571009 date "2022-11-01" @default.
• W4310571009 modified "2023-09-25" @default.
• W4310571009 title "Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer" @default.
• W4310571009 cites W1957742134 @default.
• W4310571009 cites W1982403224 @default.
• W4310571009 cites W1988476050 @default.
• W4310571009 cites W2019105683 @default.
• W4310571009 cites W2019294726 @default.
• W4310571009 cites W2035346960 @default.
• W4310571009 cites W2054195724 @default.
• W4310571009 cites W2072564984 @default.
• W4310571009 cites W2096143664 @default.
• W4310571009 cites W2096258722 @default.
• W4310571009 cites W2101844536 @default.
• W4310571009 cites W2107977954 @default.
• W4310571009 cites W2119151801 @default.
• W4310571009 cites W2135504026 @default.
• W4310571009 cites W2159060826 @default.
• W4310571009 cites W2368819226 @default.
• W4310571009 cites W2547145665 @default.
• W4310571009 cites W2550185523 @default.
• W4310571009 cites W2550856922 @default.
• W4310571009 cites W2571458784 @default.
• W4310571009 cites W2594059953 @default.
• W4310571009 cites W2595713273 @default.
• W4310571009 cites W2945968242 @default.
• W4310571009 cites W2946128073 @default.
• W4310571009 cites W2979035301 @default.
• W4310571009 cites W3010860768 @default.
• W4310571009 cites W3108059695 @default.
• W4310571009 cites W3159924581 @default.
• W4310571009 cites W3161203370 @default.
• W4310571009 cites W3175499653 @default.
• W4310571009 cites W3200616010 @default.
• W4310571009 cites W4205425016 @default.
• W4310571009 cites W4283332403 @default.
• W4310571009 doi "https://doi.org/10.1200/po.22.00390" @default.
• W4310571009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36446043" @default.
• W4310571009 hasPublicationYear "2022" @default.
• W4310571009 type Work @default.
• W4310571009 citedByCount "2" @default.
• W4310571009 countsByYear W43105710092023 @default.
• W4310571009 crossrefType "journal-article" @default.
• W4310571009 hasAuthorship W4310571009A5001066329 @default.
• W4310571009 hasAuthorship W4310571009A5002118134 @default.
• W4310571009 hasAuthorship W4310571009A5016499103 @default.
• W4310571009 hasAuthorship W4310571009A5019837009 @default.
• W4310571009 hasAuthorship W4310571009A5019914745 @default.
• W4310571009 hasAuthorship W4310571009A5020118706 @default.
• W4310571009 hasAuthorship W4310571009A5020879855 @default.
• W4310571009 hasAuthorship W4310571009A5024176070 @default.
• W4310571009 hasAuthorship W4310571009A5030221990 @default.
• W4310571009 hasAuthorship W4310571009A5030622261 @default.
• W4310571009 hasAuthorship W4310571009A5034426537 @default.
• W4310571009 hasAuthorship W4310571009A5035004148 @default.
• W4310571009 hasAuthorship W4310571009A5043164726 @default.
• W4310571009 hasAuthorship W4310571009A5044409970 @default.
• W4310571009 hasAuthorship W4310571009A5046068707 @default.
• W4310571009 hasAuthorship W4310571009A5052728382 @default.
• W4310571009 hasAuthorship W4310571009A5053521833 @default.
• W4310571009 hasAuthorship W4310571009A5055885197 @default.
• W4310571009 hasAuthorship W4310571009A5056053037 @default.
• W4310571009 hasAuthorship W4310571009A5061278042 @default.
• W4310571009 hasAuthorship W4310571009A5063780804 @default.
• W4310571009 hasAuthorship W4310571009A5066809288 @default.
• W4310571009 hasAuthorship W4310571009A5071375150 @default.
• W4310571009 hasAuthorship W4310571009A5072705088 @default.
• W4310571009 hasAuthorship W4310571009A5083449660 @default.
• W4310571009 hasAuthorship W4310571009A5084270347 @default.
• W4310571009 hasBestOaLocation W43105710091 @default.
• W4310571009 hasConcept C121608353 @default.
• W4310571009 hasConcept C126322002 @default.

• next